F

FAICIC Clinical Research | Veracruz, Mexico

Research site

(Unclaimed)

Location

Av. 16 de septiembre 1165, Veracruz, Veracruz, Mexico

Site insights

Top conditions

Top treatments

Pembrolizumab

Ritonavir

PF-07321332

Gemcitabine

MK-3475-630

paclitaxel

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 6 total trials

A Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008)

The current study will compare pembrolizumab (MK-3475) plus maintenance olaparib, vs. pembrolizumab plus maintenance olaparib placebo for the treatme...

Active, not recruiting

Carcinoma, Squamous Cell, Non-small-cell Lung

Drug: Olaparib

Drug: Paclitaxel

Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)

Brief Summary:The study is a prospective, randomized controlled phase III trial aimed to test the efficacy and safety of Tumor Treating Fields (TTFie...

Active, not recruiting

Pancreas Adenocarcinoma

Drug: nab paclitaxel

Drug: Gemcitabine

Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)

This is a randomized, double-blind, study that compares pembrolizumab (MK-3475) with placebo given as adjuvant therapy in participants with high-risk...

Active, not recruiting

Carcinoma, Squamous Cell

Drug: Placebo

Biological: Pembrolizumab 400 mg

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms